Cargando…
Treatment optimization of pelvic external beam radiation and/or vaginal brachytherapy for patients with stage I to II high-risk Endometrioid adenocarcinoma: a retrospective multi-institutional analysis
BACKGROUND: For stage I to II high-risk endometrioid adenocarcinoma patients, the optimal adjuvant radiotherapy modality remains controversial. The present study sought to optimize the treatment of pelvic external beam radiation (EBRT) with/or vaginal brachytherapy (VBT) for high-risk endometrioid a...
Autores principales: | Wang, Wenhui, Zou, Lijuan, Wang, Tiejun, Liu, Zi, He, Jianli, Sun, Xiaoge, Zhong, Wei, Zhao, Fengju, Li, Xiaomei, Li, Sha, Zhu, Hong, Ma, Zhanshu, Sun, Shuai, Jin, Meng, Zhang, Fuquan, Hou, Xiaorong, Wei, Lichun, Hu, Ke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255000/ https://www.ncbi.nlm.nih.gov/pubmed/34217240 http://dx.doi.org/10.1186/s12885-021-08524-x |
Ejemplares similares
-
Effect of age as a continuous variable in early-stage endometrial carcinoma: a multi-institutional analysis in China
por: Sun, Shuai, et al.
Publicado: (2021) -
Utilization Trend and Comparison of Different Radiotherapy Modes for Patients with Early-Stage High-Intermediate-Risk Endometrial Cancer: A Real-World, Multi-Institutional Study
por: Ren, Kang, et al.
Publicado: (2022) -
Overview of adjuvant radiotherapy on survival, failure pattern and toxicity in stage I to II endometrial carcinoma: a long-term multi-institutional analysis in China
por: Wang, Wenhui, et al.
Publicado: (2022) -
Practice patterns of adjuvant radiotherapy in women with stage I to II endometrial carcinoma: a real-world multi-institutional analysis in China
por: Wang, Wenhui, et al.
Publicado: (2023) -
Comparing multichannel cylinder and 3D-printed applicators for vaginal cuff brachytherapy with preliminary exploration of post-hysterectomy vaginal morphology
por: Yan, Junfang, et al.
Publicado: (2021)